Stephen Lahue Cartt - Net Worth and Insider Trading
Stephen Lahue Cartt Net Worth
The estimated net worth of Stephen Lahue Cartt is at least $389,004 dollars as of 2024-11-10. Stephen Lahue Cartt is the President and CEO of Asterias Biotherapeutics Inc and owns about 260,000 shares of Asterias Biotherapeutics Inc (AST) stock worth over $245,700. Stephen Lahue Cartt is also the Director of Lineage Cell Therapeutics Inc and owns about 155,125 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $143,304. Details can be seen in Stephen Lahue Cartt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen Lahue Cartt has not made any transactions after 2016-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen Lahue Cartt
Stephen Lahue Cartt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Lahue Cartt owns 2 companies in total, including Asterias Biotherapeutics Inc (AST) , and Lineage Cell Therapeutics Inc (LCTX) .
Click here to see the complete history of Stephen Lahue Cartt’s form 4 insider trades.
Insider Ownership Summary of Stephen Lahue Cartt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AST | Asterias Biotherapeutics Inc | 2018-06-21 | director |
| LCTX | Lineage Cell Therapeutics Inc | 2015-08-18 | director |
Stephen Lahue Cartt Latest Holdings Summary
Stephen Lahue Cartt currently owns a total of 2 stocks. Among these stocks, Stephen Lahue Cartt owns 260,000 shares of Asterias Biotherapeutics Inc (AST) as of June 30, 2016, with a value of $245,700 and a weighting of 63.16%. Stephen Lahue Cartt also owns 155,125 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 18, 2015, with a value of $143,304 and a weighting of 36.84%.
Latest Holdings of Stephen Lahue Cartt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AST | Asterias Biotherapeutics Inc | 2016-06-30 | 260,000 | 0.95 | 245,700 |
| LCTX | Lineage Cell Therapeutics Inc | 2015-08-18 | 155,125 | 0.92 | 143,304 |
Holding Weightings of Stephen Lahue Cartt
Stephen Lahue Cartt Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen Lahue Cartt has made a total of 0 transactions in Asterias Biotherapeutics Inc (AST) over the past 5 years. The most-recent trade in Asterias Biotherapeutics Inc is the acquisition of 10,000 shares on June 30, 2016, which cost Stephen Lahue Cartt around $24,000.
According to the SEC Form 4 filings, Stephen Lahue Cartt has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 75,000 shares on August 18, 2015, which cost Stephen Lahue Cartt around $210,000.
Insider Trading History of Stephen Lahue Cartt
- 1
Stephen Lahue Cartt Trading Performance
GuruFocus tracks the stock performance after each of Stephen Lahue Cartt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen Lahue Cartt is 44.63%. GuruFocus also compares Stephen Lahue Cartt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen Lahue Cartt within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen Lahue Cartt's insider trading performs compared to the benchmark.
Performance of Stephen Lahue Cartt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.56 | | | | | |
| Relative Return to S&P 500(%) | 17.04 | | | | | |
Stephen Lahue Cartt Ownership Network
Ownership Network List of Stephen Lahue Cartt
Ownership Network Relation of Stephen Lahue Cartt
Stephen Lahue Cartt Owned Company Details
What does Asterias Biotherapeutics Inc do?
Who are the key executives at Asterias Biotherapeutics Inc?
Stephen Lahue Cartt is the director of Asterias Biotherapeutics Inc. Other key executives at Asterias Biotherapeutics Inc include other: See Remarks Below Neal C Bradsher , other: See Remarks Below Broadwood Partners Lp , and other: See Remarks Below Broadwood Capital Inc .
Asterias Biotherapeutics Inc (AST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Asterias Biotherapeutics Inc (AST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Asterias Biotherapeutics Inc (AST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Asterias Biotherapeutics Inc (AST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Asterias Biotherapeutics Inc Insider Transactions
Stephen Lahue Cartt Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Lahue Cartt. You might contact Stephen Lahue Cartt via mailing address: 1300 N. Kellogg Drive, Suite D, Anaheim Ca 92807.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
